Ruesch Center's Avatar

Ruesch Center

@rueschcenter

Lombardi Comprehensive Cancer Center's GI clinicians and researchers working together to combine expertise in molecular medicine, novel therapeutics, translational research, and a patient-centered philosophy to improve outcomes for GI Cancer patients

84
Followers
210
Following
65
Posts
30.01.2025
Joined
Posts Following

Latest posts by Ruesch Center @rueschcenter

Preview
New York Magazine Colorectal cancer is the second-most-common cause of cancer fatalities in the United States, with 150,000 diagnoses annually and 52,000 deaths; only lung cancer kills more. It has grabbed headlines...

Read Abraham’s full essay on her diagnosis and journey with colon cancer with interviews from other survivors, advocates, and clinicians, including Dr. John Marshall.

28.08.2025 02:57 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Liquid, Tissue, or Both? Expediting Next-Generation Sequencing Results to Guide Treatment Selection in Patients With Metastatic Colorectal Cancer Knowledge of biomarkers is critical to guide first-line treatment selection in patients with metastatic colorectal cancer. Liquid biopsies and tissue-based sequencing tests have different advantages, ...

Liquid, Tissue, or Both? Expediting Next-Generation Sequencing Results to Guide Treatment Selection in Patients With Metastatic Colorectal Cancer dailynews.ascopubs.org/do/liquid-ti...

28.08.2025 02:51 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Fit, Young, and at Risk for Precancerous Colon Lesions? Study finds that extreme runners may have a higher risk of colon cancer, but it's not clear why

Fit, Young, and at Risk for Precancerous Colon Lesions? www.medpagetoday.com/gastroentero...

26.08.2025 15:25 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Join us tomorrow morning, Friday, June 27th, from 9:00- 10:30 am, to review research from the #ASCO25 Annual Meeting. We will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers via Zoom. Register now: bit.ly/4k63Swd to receive the link.

26.06.2025 23:11 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

"Badge-up" with @marshalj23.bsky.social of @georgetownlombardi.bsky.social as he discusses #ASCO25 with @clinicalcaresol.bsky.social. Watch now: clinicalcaresolutions.net/activities/o...

12.06.2025 20:40 πŸ‘ 3 πŸ” 3 πŸ’¬ 0 πŸ“Œ 0
Preview
The Hidden Barriers Holding Back Promising Cancer Treatments A perfect storm of scientific, economic, and cultural barriers are holding back immunotherapy's true potential, writes Samir Khleif.

The Hidden Barriers Holding Back Cancer's Most Promising Treatments: Samir N. Khleif, MD of @georgetownlombardi.bsky.social shares his thoughts on the pace of innovation in immune checkpoint inhibitors.

time.com/7292783/canc...

11.06.2025 22:05 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
GI Cancer Patient Summit: Saturday, July 12, 2025. - The Ruesch Center for the Cure of Gastrointestinal Cancers We are looking forward to the 10th Annual GI Cancer Patient Summit. The Summit is a partnership between The Ruesch Center and Hope Connections for Cancer Support. This year’s topics are still in devel...

We are excited to celebrate our 10th Annual GI Cancer Patient Summit with Hope Connections for Cancer Support and @georgetownlombardi.bsky.social on Saturday, July 12, 2025, from 10:00 am- 1:00 pm EST. The summit provides information and tools to manage cancer care. Learn more: bit.ly/GISummit25

11.06.2025 22:03 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
EGFR Inhibitors in the Treatment of Stage IV CRC Benjamin A. Weinberg, MD discusses EGFR inhibitors in the treatment of stage IV CRC.

EGFR Inhibitors in the Treatment of Stage IV CRC:
Benjamin Weinberg, MD, discusses with @medscape.com Hematology and Oncology Decision Point.

decisionpoint.medscape.com/oncology/vie...

11.06.2025 22:02 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Join @medstarhealth.bsky.social for the 2025 Esophageal Symposium. Attendees will gain insights into identifying the pathophysiology associated with esophageal conditions, as well as guidance on testing, indications for therapy, and available endoscopic and surgical treatments. bit.ly/3FHX6On

05.06.2025 23:42 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

After #ASCO25, stay up-to-date on the latest GI Cancer Research. View this week's tailored GI Cancer publication output via bit.ly/454GquF and sign up to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub.

02.06.2025 23:33 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

Join us to review exciting research from the #ASCO25 Annual Meeting. Drs. Marshall, Weinberg, Noel, and Mukherji will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers on June 27th via Zoom. Register today: bit.ly/4k63Swd @georgetownlombardi.bsky.social.

02.06.2025 23:30 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Unmet Needs and Therapy Modifications Relevant in the CRC Landscape John L. Marshall, MD, discusses unmet needs in the targeted therapy space and the importance of optimizing dosing in colorectal cancer.

John L. Marshall, MD, (@marshalj23.bsky.social) discusses unmet needs in the targeted therapy space and the importance of optimizing dosing in colorectal cancer with @targetedonc.bsky.social. www.targetedonc.com/view/unmet-n...

22.05.2025 16:55 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

Today, on Clinical Trials Day, we recognize and celebrate the contributions of clinical research professionals in advancing research at Lombardi Comprehensive Cancer Center. The Lombardi Clinical Trials Office provides administrative, nursing, and data management support for clinical trials.

20.05.2025 21:53 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Register today for the 10th Annual GI Cancer Patient Summit on Saturday, July 12, 2025, from 10:00 am- 1:00 pm EST. The summit provides information and tools to manage cancer care. This free event is a partnership with Hope Connections for Cancer Support. bit.ly/GISummit25

19.05.2025 20:10 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
BellRinger | Team Ruesch Support me as I fundraise for cancer research at Georgetown Lombardi Comprehensive Cancer Center

Learn more about BellRinger today! Join Team Ruesch as a rider, volunteer, or supporter as we gear up for BellRinger on October 24-25, 2025. 100% of funds raised from BellRinger support cancer research at @georgetownlombardi.bsky.social. bit.ly/RueschBellRinger

16.05.2025 22:08 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

This week, we highlighted research by Emil Lou (@cancerassassin1.bsky.social), Modassir S Choudhry, Timothy K Starr, Timothy D Folsom, Jason Bell, Blaine Rathmann, Anthony P DeFeo, Jihyun Kim, Branden S Moriarity, and others published in @thelancetoncol.bsky.social. Learn more: bit.ly/3Fkx2bI.

15.05.2025 23:16 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer.
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer. YouTube video by The Ruesch Center

In this week's Ruesch Center GI Cancers publication search, @marshalj23.bsky.social highlighted research by Julien Taieb, Pierre Laurent-Puig, and others published in the Journal of Clinical Oncology. bit.ly/3Fkx2bI. Learn more: youtu.be/JlqL1f6vyak?...

15.05.2025 22:46 πŸ‘ 1 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

On Thursday, May 15th, join thousands of commuters in the DMV for Bike to Work Day! BellRinger will host its own stop at Georgetown Waterfront Park. Stop by to learn how to gear up to support critical research at @georgetownlombardi.bsky.social . Register today: bit.ly/4k5BABC.

09.05.2025 17:23 πŸ‘ 2 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

View this week's tailored GI Cancer publication output via bit.ly/431rg6J. Sign up today to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub. What research excited you this week?

08.05.2025 22:03 πŸ‘ 1 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

Join Smith Center for the Healing and the Arts, Hope Connections for Cancer Support Community, Washington, D.C., and Cancer Choices for this virtual event on Wednesday, May 21st. Learn more and register today: smithcenter.org/programs-ret...

05.05.2025 23:52 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

This week, we highlighted research by Jill P Smith, Narayan Shivapurkar, Wenqiang Chen, Godhanjali Chekuri, Amani Dabney, Kyle Holmes, Hong Cao, Ruvanthi N Kularatne, and Stephan T Stern published in the Journal of Molecular Cancer Therapeutics. Learn more: bit.ly/4lTknwY

30.04.2025 22:25 πŸ‘ 1 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

Save the Date for the 16th Annual Ruesch Center Symposium- Nov 21-22, 2025! @georgetownlombardi.bsky.social @marshalj23.bsky.social @onclive.bsky.social @medstarhealth.bsky.social

30.04.2025 17:48 πŸ‘ 1 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image Post image Post image

Pancreatic Cancer 2025: After More Than 30 Years, Is That Light on the Horizon? @marshalj23.bsky.social shares insights in the Spring Issue of Oncolytics Today. Read the full article, pages 77-79-https://www.ncoda.org/news/oncolytics-today-spring-2025/

23.04.2025 17:58 πŸ‘ 2 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Preview
Managing Colorectal Cancer Requires Using All Available Options In an interview with Peers & Perspectives in Oncology, John L. Marshall, MD, discussed treatment approaches and sequencing for refractory colorectal cancer.

In an interview with Peers & Perspectives in Oncology, Dr. John Marshall discussed treatment approaches and sequencing for refractory colorectal cancer.
www.targetedonc.com/view/managin...

23.04.2025 17:21 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

This week, we highlighted exciting research by Berend J van der Wilk, Ben M Eyck, Bas P L Wijnhoven, Sjoerd M Lagarde, J Jan B van Lanschot, and others published in @thelancetoncol.bsky.social. Learn more: bit.ly/3GkX52V.

22.04.2025 23:40 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

Nominations are open for the 2025 Luminary Awards in GI Cancers! Submit your colleagues who have transformed the lives of GI cancer patients. Categories include MedOnc, Pre-clinical, Nursing, Surgery, and Advocacy. Awards will be presented on November 20th in D.C. bit.ly/LuminaryNomination

14.04.2025 18:44 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
BESPOKE: ctDNA Clearance During and After ACT Panelists discuss how circulating tumor DNA (ctDNA) clearance rates during and after adjuvant chemotherapy (ACT) in the BESPOKE trial provide critical insights into treatment efficacy and may serve as...

@marshalj23.bsky.social and @marklewismd.bsky.social discuss how ctDNA clearance rates during and after adjuvant chemotherapy (ACT) in the BESPOKE trial provide critical insights into treatment efficacy and may serve as an early predictor of long-term patient outcomes. bit.ly/4luOsmd

14.04.2025 16:47 πŸ‘ 1 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

This week, we highlighted research by Zhihao Lu, Wenting Du, Xi Jiao, Lin Shen, and others published in the Journal of Clinical Oncology. Learn more: bit.ly/43KNnAs.

11.04.2025 18:28 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Targeted Therapy Options Sometimes Underutilized in Metastatic CRC John L. Marshall, MD, discusses the sequencing of targeted therapy for refractory metastatic colorectal cancer.

Targeted Therapy Options Sometimes Underutilized in Metastatic CRC. @marshalj23.bsky.social, discusses the sequencing of targeted therapy for refractory metastatic colorectal cancer.

www.targetedonc.com/view/targete...

10.04.2025 16:56 πŸ‘ 1 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Preview
Episode 13 | CCS As a nationally recognized provider of continuing education for healthcare professionals, CCS develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities.

Mass layoffs. Funding cuts. Uncertain futures.
@marshalj23.bsky.social unpacks the turmoil hitting federal health agencies and what it means for researchers, clinical trials, and patient care. Who benefits from this chaos, and how can the medical community push back?

bit.ly/42nXXLw

08.04.2025 22:02 πŸ‘ 1 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0